You are here

Abuse Potential of Orally Administered Crushed Embeda Compared to Crushed Controlled-Release Morphine and Placebo in Non-Dependent Recreational Opioid Users

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Lifetree Clinical Research
Salt Lake City, Utah, 84106 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Episodic Nondependent Opioid Abuse
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-55 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Subject is a recreational opioid user who is NOT physically dependent on opioids based
on Diagnostic and Statistical Manual of Mental Disorders-Fourth Edition-Text Revision
(DSM-IV-TR) criteria, and the Naloxone Challenge. A recreational opioid user is
defined as recreationally abusing opioids for non-therapeutic purposes (i.e., for
psychoactive effects) on at least 10 occasions within the last year and at least once
in the 12 weeks prior to Visit 1.

- Subject is in generally good health as determined by medical history, physical
examination, vital signs, clinical laboratory tests, and 12-lead electrocardiogram
(ECG).

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Has a history or current diagnosis of substance dependence (excluding caffeine and
nicotine), as assessed by the Investigator using the DSM IV-TR criteria.

- Has participated in, is currently participating in, or is seeking treatment for
substance- and/or alcohol-related disorders (excluding nicotine and caffeine).

- History or presence of any clinically significant illness (e.g., cardiovascular,
pulmonary, hepatic, renal, hematologic, gastrointestinal, endocrine, immunologic,
dermatologic, neurologic, oncologic, musculoskeletal, or psychiatric) or any other
condition, which in the opinion of the Investigator would jeopardize the safety of the
subject or the validity of the study results.

- Has a known allergy or history of hypersensitivity to morphine sulfate, opioids in
general, naltrexone hydrochloride (HCl) or similar compounds and/or the known
excipients in the investigational drug products.

- Has any condition in which an opioid is contraindicated (e.g., significant respiratory
depression, acute or severe bronchial asthma or hypercarbia, or is suspected of having
paralytic ileus).

- Females who are pregnant, lactating, or are planning to become pregnant during the
course of the study. Females with a positive serum pregnancy test at Visit 1 or at any
subsequent study visit will be excluded from participating in the study.

NCT01380093
Pfizer
Completed
Abuse Potential of Orally Administered Crushed Embeda Compared to Crushed Controlled-Release Morphine and Placebo in Non-Dependent Recreational Opioid Users

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now